The company announces FDA clearance for its Alzheimer’s disease Cerebrospinal Fluid (CSF) assays The Elecsys® Alzheimer’s disease (AD) CSF assays will…
La compañía anuncia la aprobación de la FDA para sus ensayos de líquido cefalorraquídeo (LCR) para la enfermedad de Alzheimer…
(PRESS RELEASE) DÜBENDORF, 3-Feb-2022 — /EuropaWire/ — Empa, the Swiss research institute for applied materials sciences and technology, has announced…
(COMUNICADO DE PRENSA) DÜBENDORF, 3-Feb-2022 — /EuropaWire/ — Empa, el instituto de investigación suizo de ciencia y tecnología de materiales…
(PRESS RELEASE) HELSINKI, 27-Dec-2021 — /EuropaWire/ — University of Helsinki, the oldest and largest institution of academic education in Finland,…
(PRESS RELEASE) MUNICH, 09-Jan-2019 — /EuropaWire/ — Defects in the geneTREM2 are linked to increased risk of Alzheimer’s disease. The gene…
GENEVA, 08-Jun-2016 — /EuropaWire/ — TESTmyBRAIN (Switzerland) has opened its first center of Functional Neurology in Europe. This non-invasive therapy…
LIVERPOOL, 4-8-2015 — /EuropaWire/ — Scientists at the University of Liverpool have, for the first time, characterised a genetic mutation…
SOUTHAMPTON, 16-12-2014 — /EuropaWire/ — Researchers in Southampton are tackling one of the biggest questions in dementia research; why might current…